Fortress Biotech, Inc. (FBIOP) Shareholders’ equity 2016–2025
Fortress Biotech, Inc. (FBIOP) shareholders’ equity at each fiscal year-end, per SEC filings.
$49.9MFY2025 · since FY2016: $38.5M → $49.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $49.9M | +119.3% |
| FY2024 | $22.7M | +0.9% |
| FY2023 | $22.5M | -46.0% |
| FY2022 | $41.7M | -61.6% |
| FY2021 | $108.7M | +8.3% |
| FY2020 | $100.3M | +282.8% |
| FY2019 | $26.2M | +1315.5% |
| FY2018 | $1.9M | -96.5% |
| FY2017 | $52.6M | +36.6% |
| FY2016 | $38.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FBIOP financial trends
FBIOP RevenueFBIOP Net incomeFBIOP Net marginFBIOP Gross profitFBIOP Gross marginFBIOP Operating incomeFBIOP Operating marginFBIOP Operating cash flowFBIOP Free cash flowFBIOP Capital expendituresFBIOP Return on equityFBIOP Stock buybacksFBIOP Dividends paidFBIOP Total assetsFBIOP Total liabilitiesFBIOP overview →